Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25252719 | 1.00 | PIN1 (0.44) | PIN1SIGMAR1RAB9ANPC1MAPT | |
| SCHEMBL2049090 | 0.86 | RECQL (0.53) | PIN1MAPTALDH1A1TDP1 | |
| SCHEMBL30491733 | 0.86 | RECQL (0.53) | PIN1MAPTALDH1A1TDP1 | |
| SCHEMBL25290375 | 0.86 | RECQL (0.53) | PIN1MAPTALDH1A1TDP1 | |
| SCHEMBL27228011 | 0.83 | TDP1 (0.46) | ALDH1A1TDP1GAA | |
| SCHEMBL30861009 | 0.83 | TDP1 (0.46) | ALDH1A1TDP1GAA | |
| SCHEMBL6118688 | 0.82 | TDP1 (0.44) | ALDH1A1TDP1GAA | |
| SCHEMBL27227989 | 0.82 | TDP1 (0.44) | MAPTALDH1A1TDP1GAA | |
| SCHEMBL3686407 | 0.79 | TDP1 (0.47) | MAPTALDH1A1TDP1GAA | |
| SCHEMBL476964 | 0.78 | CNR1 (0.46) | RAB9ANPC1MAPTALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118748993-A | Indazole compounds and medicaments | 日本新药株式会社 | 2024-10-08 | — | — | CN | disclosed |